This article refers to:
In the article: Amiri MM, Jeddi-Tehrani M, Kazemi T et al. Construction and characterization of a new chimeric antibody against HER2. Immunotherapy 5(7), 703–715 (2013) (http://www.tandfonline.com/doi/pdf/10.2217/imt.13.67), it has come to our attention that Motahareh Bahadori and Mohammad Hojjat-Farsangi were incorrectly spelt as:
Motahhare Bahadori, Mohammad Hojjat-Farsanghi
The correct spellings are:
Motahareh Bahadori, Mohammad Hojjat-Farsangi
The authors and editors of Immunotherapy would like to sincerely apologize for any confusion or inconvenience caused.